Hims & Hers Health (NYSE:HIMS) has launched Labs AI, an AI care agent that provides users with personalized, clinically vetted interpretations of their lab results. The company is also expanding into ...

Online health and wellness company Hims & Hers posted a $92 million loss in the first quarter as it transitions its weight loss business to selling branded GLP-1 weight loss treatments, shifting away ...

Researchers have created a next-generation obesity drug that works like a “Trojan horse,” using GLP-1/GIP signals to slip a ...

Hims & Hers launched an artificial intelligence agent embedded in its platform to help interpret biomarker lab results and ...

PureHealth Research is proud to introduce its advanced line of Berberine-infused metabolic formulas, developed to work in harmony with the body's own biology. These scientifically formulated products ...

Companies confirm that markers of weight loss and glycemic control are distinct in preliminary study, with multiple mechanisms identified that provide opportunities to guide indication extension ...

Amazon said customers can access real-time medication availability, transparent pricing, and same-day delivery. ・Citi previously noted that Amazon’s healthcare model still differs from ...

Miami Gardens Clinic Launches Telehealth Access to Tirzepatide and Semaglutide with Same-Day Appointments.

KELOWNA, BC / / May 5, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in ...

Neuland enters development collaboration with LIR Life Sciences for transdermal GLP-1: Our Bureau, Bengaluru Thursday, May 7, 2026, 13:30 Hrs [IST] Neuland Laboratories, a global ...

Neuland secures development collaboration with LIR Life Sciences for transdermal GLP-1CDMO to advance biotech’s novel ...

SiPhox Health makes at‑home blood testing easy with up to 60 biomarkers starting at $99 — no needles, no lab visits, just ...